Your session is about to expire
← Back to Search
Real-time gait biofeedback (RTGBF) for Osteoarthritis
Study Summary
This trial found that real-time gait biofeedback can improve early indicators of post-traumatic osteoarthritis development in those who have had an ACLR.
- Posttraumatic Osteoarthritis
- Anterior Cruciate Ligament Injury
- Knee Injuries
- Osteoarthritis
- Articular Cartilage
- Gait
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Would I be eligible to participate in this clinical experiment?
"This research study is open to young adults aged 18-35 with gait issues, and aims to recruit a total of 70 participants."
Are there still opportunities available to join this clinical research?
"Clinicaltrials.gov confirms that recruitment is ongoing for this particular medical trial, which was posted on August 5th 2021 and amended most recently on October 11th 2022."
Is eligibility for this trial restricted to individuals aged 55 and younger?
"This medical trial has set 18 years old as the minimum age for enrollment and 35 years old as the maximum."
How many individuals have thus far enrolled in this experiment?
"Affirmative. According to the information posted on clinical trials .gov, this medical trial which debuted on August 5th 2021 is presently seeking applicants. The study intends to recruit 70 participants from one site."
What goals is this clinical trial intending to accomplish?
"The primary goal of this trial, the results of which will be measured after week 4 and 8 respectively, is to determine how many participants were recruited through different recruitment methods. Secondary objectives include measuring changes in Tegner Activity Scale score (a 11-point Likert scale used to quantify activity levels for individuals with ACL injury), peak knee flexion excursion (gait biomechanics collected using an eight camera three-dimensional motion analysis system while walking on a dual-belt, force-sensing treadmill) and joint tissues metabolism by assessing degenerative matrix metalloproteinase-3 (MMP-3) enzyme. Blood samples"
Share this study with friends
Copy Link
Messenger